Influence of pentoxifylline and dispirin on aggregation and cleformability of erythrocytes under in vitro conditions

Indian Journal of Biochemistry and Biophysics

Volumn 33, Issue 3, 1996, Pages 199-205

  Singh, Megha ^a   Kumaravel, M ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PENTOXIFYLLINE; VASODILATOR AGENT;

ARTICLE; CELL AGGREGATION; CYTOLOGY; DRUG EFFECT; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; HUMAN; IN VITRO STUDY; PHYSIOLOGY;

ASPIRIN; CELL AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; HUMANS; PENTOXIFYLLINE; VASODILATOR AGENTS;

EID: 0030159122     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Leonhardt H & Grigoleit H G (1977) Arch Pharmacol 299, 197.
2. Ehrly A M (1976) Angiology 27, 188.
3. Smud R, Sermukslis B & Kartni D (1976) Pharmatherapeutica 1, 229.
4. Vigneron C & Stolz J (1977) Medicine Actuelle 4, 200.
5. Gastpar H (1974) Thrombosis Res 5, 277.
6. Kuzuya F (1977) Gendai No Shinryo 19, 1567.
7. Angelkort B, Maurin N & Buatneg K (1979) Curr Med Res Opinion 6, 255.
8. Muller R (1979) J Med 10, 307.
9. Muller R & Lebrach F (1981) Curr Med Res Opinion 7, 253.
10. Splawinski J, Correl T, Hasselmann G & Mruck J (1982) Thromosis Res 25, 155.
11. Takeda H, Fukuuchi Y, Tomita M, Tanahashi N & Kanno S (Personal Communication).
12. Schmid-Schonbein H & Volger E (1976) Diabetes 25, 897.
13. Gasper-Rosas A & Thurston G B (1988) Biorheology, 25, 471.
14. Sowemimo-Cocker S D, Whittingstall P, Pietsch S, Bauersachs R M, Wenby R B & Meiselman H J (1989) Clin Hemorheol 9, 723.
15. Donner M, Mills P & Stoltz J F Clin (1989) Hemorheology 9, 715.
16. Muralidharan E & Singh M (1988) Clin Hemorheol 8, 715.
17. Muralidharan E & Singh M (1991) Clin Hemorheol 11, 205.
18. Singh M & Muralidharan E (1988) Biorheology 25, 237.
19. Kumaravel M, Kasthurirangan S P & Singh M (1995) Current Sci 68, 618.
20. Kumaravel M & Singh M (1995) Indian J Exp Biol 33, 408.
21. Skalak R, Zarda P R, Jan K M & Chien S (1981) Biophys 735, 771.
22. Chien S (1975) The Red Blood Cell (D M Surgenor ed) Vol. 2, pp 1031-1133 (Academic Press, New York).
23. Singh M & Vatsala T M (1982) Biorheology 19, 539.
24. Singh M & Kumaravel M (1994) Comp Biomed Res 27, 325.
25. Kanakaraj P & Singh M (1989) Atherosclerosis 76, 209.
26. Singh M, Middleberg J, Ramachandran G & Rath H J (1993) Microgravity Sci Technol 6, 39.
27. Kumaravel M & Singh M (1995) Clin Hemorheol 15, 291.
28. Grigobit H & Leonhardt H (1977) Pharmatherapeutica 1, 642.
29. Teitel P, Schmid-Schonbein H, Gaehtgens P & Mussler K (1981) Proc Second Internat Symp Nootropic Drugs, Mexico City, pp 198-212.
30. Lebrach F & Grigolett H G (1979) Curr Med Res Opinion 6, Suppl. 4, 49.
31. Ehrly A M (1978) Curr Med Res Opinion 5, 608.
32. Stefanovich V (1978) Pharmatherapeutica 2, 5.
33. Nakao M, Nakao T & Yamazoe S (1960) Nature, London 187, 945.